Table 3.
Evaluation of laboratory findings of the groups
| TMSC (million) | |||||
|---|---|---|---|---|---|
| <5 n=38 | 5–10 n=14 | 10–20 n=34 | >20 n=144 | p | |
| WBC count | 7.61 (6.74, 8.63) | 8.25 (7.93, 10.2) | 7.2 (6.27, 8.46) | 7.83 (6.75, 9.8) | 0.049 * |
| Neutrophil ratio (%) | 56.7 (54.55, 61.4) | 58.05 (54.5, 63.1) | 56.1 (51, 62.4) | 57.4 (52.7, 61.75) | 0.701 |
| Neutrophil count | 4.33 (3.46, 5.3) | 5.02 (4.49, 5.35) | 4.37 (3.33, 4.97) | 4.46 (3.77, 5.43) | 0.068 |
| Lymphocyte count | 2.46 (2.25, 2.78) | 2.63 (2.2, 3.12) | 2.27 (1.82, 2.68) | 2.52 (2.06, 3.06) | 0.142 |
| PLT count | 253.5 (217.5, 288) | 258.5 (224, 284) | 220 (188, 285) | 257 (215, 291) | 0.275 |
| N/L | 1.65 (1.43, 1.96) | 1.8 (1.67, 2.23) | 1.79 (1.32, 2.18) | 1.79 (1.44, 2.16) | 0.601 |
| P/L | 100.13 (85.6, 123.9) | 93.43 (72.73, 121.7) | 98.47 (86.9, 119.7) | 100.89 (84.98, 120.58) | 0.951 |
| HGB | 15.25 (14.5, 15.95) | 15.85 (15.5, 16.1) | 15.5 (15, 16.1) | 15.75 (15.1, 16.4) | 0.070 |
| HCT | 44.75 (42.5, 46.6) | 46.85 (45.4, 47.8) | 44.8 (43.7, 47.5) | 45.65 (43.9, 47.7) | 0.085 |
| FSH (mIU/mL) | 4.68 (2.89, 6.23) | 4.98 (3.49, 8.4) | 4.08 (2.87, 5.7) | 3.03 (2.13, 4.45) | <0.001** |
| LH (mIU/mL) | 3.65 (2.9, 5.16) | 2.97 (2.3, 4.34) | 3.65 (2.94, 4.89) | 2.96 (2.11, 4.24) | 0.017 * |
| TSH | 1.17 (0.94, 1.99) | 1.37 (0.95, 1.66) | 1.36 (1.01, 1.84) | 1.33 (1.03, 1.92) | 0.862 |
| PRL | 7.98 (6.47, 11.35) | 9.51 (8.28, 12.49) | 9.37 (6.64, 15.03) | 9.74 (7.43, 13.55) | 0.409 |
WBC: White blood cell; PLT: Platelet; N/L: Neutrophil to lymphocyte ratio; P/L: Platelet to lymphocyte ratio; HGB: Hemoglobin; HCT: Hemotocrit; FSH: Follicle-stimulating hormone; LH: Luteinizing hormone; TSH: Thyroid stimulating hormone; PRL: Prolactin; Kruskal-Wallis test, reported as median (first quartile, third quartile); *: P<0.05; **: P<0.01.